Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)
NCT03263962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 502
Last updated 2018-02-05
Summary
To evaluate canrenone effects compared to other therapies on cardiovascular mortality in patients with congestive heart failure and preserved systolic function after 12 years of evaluation.
Conditions
- Cardiac Heart Failure Patients
Interventions
- DRUG
-
Canrenone
Evaluation of canrenone therapy in patients with CHF
Sponsors & Collaborators
-
University of Pavia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-13
- Primary Completion
- 2017-09-10
- Completion
- 2017-11-30
Countries
- Italy
Study Locations
More Related Trials
-
Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product
NCT02804282 ·Status: COMPLETED ·Phase: PHASE3
-
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
NCT03994874 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Exogenous Ketones for Acutely Decompensated HEart Failure
NCT04698005 ·Status: UNKNOWN ·Phase: PHASE3
-
CD-NP in Subjects With Stable Chronic Heart Failure
NCT00620308 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy
NCT03380520 ·Status: COMPLETED ·Phase: PHASE4
-
Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)
NCT00634309 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure
NCT00839007 ·Status: COMPLETED ·Phase: PHASE2
-
Troponin I Release After High Diuretic Doses
NCT01419132 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Cenderitide in Stable Chronic Heart Failure
NCT02359227 ·Status: COMPLETED ·Phase: PHASE2
-
Diuretic Efficacy of Dexamethasone in Heart Failure
NCT00263302 ·Status: SUSPENDED ·Phase: PHASE1
-
Effect of Carvedilol Rapid Up-Titration in Patients With Heart Failure With Reduced Ejection Fraction
NCT05179070 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
NCT00050076 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
NCT01439789 ·Status: TERMINATED ·Phase: PHASE3
-
The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial
NCT02454751 ·Status: COMPLETED ·Phase: PHASE2
-
Canakinumab in Covid-19 Cardiac Injury (The Three C Study)
NCT04365153 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-comparison Study of Prednisone in Heart Failure
NCT01559727 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
NCT01541202 ·Status: TERMINATED ·Phase: PHASE3
-
Acute Oral Ketones or Carbohydrate Supplement Modify Heart Function in Heart Failure?
NCT05651529 ·Status: COMPLETED ·Phase: NA
-
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
NCT01131637 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure
NCT00517426 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure
NCT04468529 ·Status: COMPLETED ·Phase: PHASE3
-
Ketones in Heart Failure - Effects on Cardiac Efficiency
NCT03073356 ·Status: COMPLETED ·Phase: PHASE2
-
Carbohydrate Antigen 125-guided Therapy in Heart Failure
NCT02008110 ·Status: COMPLETED ·Phase: PHASE4
-
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.
NCT03388593 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of CLR325 in Chronic Stable Heart Failure Patients.
NCT02696967 ·Status: COMPLETED ·Phase: PHASE2